Search Results 891-900 of 19319 for Hemoglobin

  1. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  2. Mayo Clinic Q and A: Understanding and treating fibroelastomas

    DEAR MAYO CLINIC: I am an 83-year-old woman on warfarin because of atrial fibrillation, and I recently was diagnosed with a fibroelastoma.

  3. Continued type 2 diabetes mellitus remission independent of weight loss observed in patients after Roux-en-Y gastric bypass - Mayo Clinic

    Baseline insulin use, higher hemoglobin A1C levels and longer preoperative duration of T2DM were associated with T2DM recurrence, while weight recurrence was ...

  4. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  5. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  6. Myelofibrosis - Symptoms and causes - Mayo Clinic

    Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.

  7. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  8. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  9. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

    Hemoglobin A1c (HbA1c) ≥ 6.5% present; or; Any (2) PDMs present on consecutive or simultaneous testing: Fasting Blood Glucose (FBG) ≥ 126 mg/dl;; Hemoglobin ...

  10. HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis - Mayo Clinic

    corrected for hemoglobin > 50% and forced expiratory volume in first second (FEV1) predicted > 50% based on most recent pulmonary function test (PFT) ...